• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哦,胱氨酸酶:让我数一数!

Oh cystinosin: let me count the ways!

机构信息

Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA; The Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.

出版信息

Kidney Int. 2019 Aug;96(2):275-277. doi: 10.1016/j.kint.2019.05.016.

DOI:10.1016/j.kint.2019.05.016
PMID:31331465
Abstract

Nephropathic cystinosis is the most common genetic cause of a renal Fanconi syndrome and results from dysfunction of the lysosomal cystine-transporter protein cystinosin. The multiple organ dysfunctions of affected patients were thought to be related to the defective protein, with cystine crystal formation. However, such crystals were not always present when looked for. More recently, study of the biology of cystinosis has expanded to include many other cellular processes that may be pathogenic in the disease, and now galectin-3 can be added to those identified.

摘要

遗传性胱氨酸贮积症是肾性范可尼综合征最常见的遗传原因,是由溶酶体胱氨酸转运蛋白胱氨酸酶功能障碍引起的。受影响患者的多种器官功能障碍被认为与缺陷蛋白和胱氨酸晶体形成有关。然而,当寻找这些晶体时并不总是能找到。最近,对胱氨酸贮积症生物学的研究已经扩展到包括许多其他可能在疾病中具有致病性的细胞过程,现在可以将半乳糖凝集素-3添加到已鉴定的过程中。

相似文献

1
Oh cystinosin: let me count the ways!哦,胱氨酸酶:让我数一数!
Kidney Int. 2019 Aug;96(2):275-277. doi: 10.1016/j.kint.2019.05.016.
2
Interaction between galectin-3 and cystinosin uncovers a pathogenic role of inflammation in kidney involvement of cystinosis.半乳糖凝集素-3 与胱氨酸蛋白酶抑制剂的相互作用揭示了炎症在胱氨酸病肾脏受累中的致病作用。
Kidney Int. 2019 Aug;96(2):350-362. doi: 10.1016/j.kint.2019.01.029. Epub 2019 Mar 6.
3
Cystinosin is a Component of the Vacuolar H+-ATPase-Ragulator-Rag Complex Controlling Mammalian Target of Rapamycin Complex 1 Signaling.胱氨酸转运体是液泡H⁺-ATP酶-Ragulator-Rag复合物的一个组成部分,该复合物控制雷帕霉素复合物1信号通路的哺乳动物靶点。
J Am Soc Nephrol. 2016 Jun;27(6):1678-88. doi: 10.1681/ASN.2014090937. Epub 2015 Oct 8.
4
Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter.胱氨酸转运蛋白,即导致胱氨酸病的缺陷蛋白,是一种由氢离子驱动的溶酶体胱氨酸转运体。
EMBO J. 2001 Nov 1;20(21):5940-9. doi: 10.1093/emboj/20.21.5940.
5
Multisystem involvement, defective lysosomes and impaired autophagy in a novel rat model of nephropathic cystinosis.新型胱氨酸病大鼠模型中的多系统受累、溶酶体缺陷和自噬受损。
Hum Mol Genet. 2022 Jul 7;31(13):2262-2278. doi: 10.1093/hmg/ddac033.
6
Molecular Mechanisms and Treatment Options of Nephropathic Cystinosis.肾性胱氨酸病的分子机制与治疗选择
Trends Mol Med. 2021 Jul;27(7):673-686. doi: 10.1016/j.molmed.2021.04.004. Epub 2021 May 8.
7
New aspects of the pathogenesis of cystinosis.胱氨酸病发病机制的新方面。
Pediatr Nephrol. 2003 Mar;18(3):207-15. doi: 10.1007/s00467-003-1077-5. Epub 2003 Feb 27.
8
Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.肾性胱氨酸病的争议和研究议程:“改善全球肾脏病预后组织”(KDIGO)争议会议的结论。
Kidney Int. 2016 Jun;89(6):1192-203. doi: 10.1016/j.kint.2016.01.033.
9
Nephropathic Cystinosis Mimicking Bartter Syndrome: a Novel Mutation.酷似巴特综合征的肾病性胱氨酸病:一种新突变
Iran J Kidney Dis. 2018 Jan;12(1):61-63.
10
Activation of the transcription factor EB rescues lysosomal abnormalities in cystinotic kidney cells.转录因子 EB 的激活可挽救胱氨酸病肾细胞中的溶酶体异常。
Kidney Int. 2016 Apr;89(4):862-73. doi: 10.1016/j.kint.2015.12.045.

引用本文的文献

1
Extrarenal complications of cystinosis.胱氨酸病的肾外并发症。
Pediatr Nephrol. 2024 Aug;39(8):2283-2292. doi: 10.1007/s00467-023-06225-0. Epub 2023 Dec 21.
2
Cysteamine bitartrate delayed-release capsules control leukocyte cystine levels and promote statural growth and kidney health in an open-label study of treatment-naïve patients <6 years of age with nephropathic cystinosis.在一项针对6岁以下初治肾病性胱氨酸病患者的开放性研究中,酒石酸半胱胺缓释胶囊可控制白细胞胱氨酸水平,并促进身高增长和肾脏健康。
JIMD Rep. 2021 Nov 1;63(1):66-79. doi: 10.1002/jmd2.12260. eCollection 2022 Jan.
3
Muscle and Bone Impairment in Infantile Nephropathic Cystinosis: New Concepts.
婴儿胱氨酸贮积症的肌肉骨骼损害:新概念。
Cells. 2022 Jan 5;11(1):170. doi: 10.3390/cells11010170.
4
Lysosome function in glomerular health and disease.溶酶体在肾小球健康和疾病中的作用。
Cell Tissue Res. 2021 Aug;385(2):371-392. doi: 10.1007/s00441-020-03375-7. Epub 2021 Jan 12.
5
Distinct Modes of Balancing Glomerular Cell Proteostasis in Mucolipidosis Type II and III Prevent Proteinuria.Ⅱ型和Ⅲ型黏脂贮积症中肾小球细胞蛋白稳态平衡的不同模式可预防蛋白尿。
J Am Soc Nephrol. 2020 Aug;31(8):1796-1814. doi: 10.1681/ASN.2019090960. Epub 2020 Jul 8.
6
Galectin-3 and Risk of Late Graft Failure in Kidney Transplant Recipients: A 10-year Prospective Cohort Study.半乳糖凝集素 3 与肾移植受者晚期移植物失功风险:一项为期 10 年的前瞻性队列研究。
Transplantation. 2021 May 1;105(5):1106-1115. doi: 10.1097/TP.0000000000003359.
7
Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy.遗传性胱氨酸病相关骨病:不只是肾性骨营养不良。
Int J Mol Sci. 2020 Apr 28;21(9):3109. doi: 10.3390/ijms21093109.
8
Adult complications of nephropathic cystinosis: a systematic review.肾性胱氨酸病的成人并发症:一项系统评价。
Pediatr Nephrol. 2021 Feb;36(2):223-236. doi: 10.1007/s00467-020-04487-6. Epub 2020 Feb 3.